Kolexia
Gligorov Joseph
Oncologie médicale
Hôpital Tenon
Paris, France
386 Activités
1.6 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeurs du sein triple-négatives Récidive tumorale locale COVID-19 Cancers du sein inflammatoires Tumeurs de l'ovaire Complications tumorales de la grossesse Tumeurs du poumon

Industries

Novartis
57 collaboration(s)
Dernière en 2023
CanceroDigest
26 collaboration(s)
Dernière en 2023
Gilead
16 collaboration(s)
Dernière en 2023
Daiichi Sankyo
15 collaboration(s)
Dernière en 2023

Dernières activités

CUPCAKE: Early Detection of Triple Negative Breast Cancer Relapse: a Clinical Utility Phase II Trial
Essai Clinique (Institut Curie)   06 mars 2024
REPARP: Prospective and Multicentric Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
Essai Clinique (Artios Pharma Ltd)   26 février 2024
QT-RIBRATING: QT on RIBociclib measuRed by ArTificial INteliGence
Essai Clinique (Hôpital Ambroise Paré)   19 février 2024
Simultaneous quantification of four hormone therapy drugs by LC-MS/MS: Clinical applications in breast cancer patients.
Journal of pharmaceutical and biomedical analysis   12 février 2024
IMpassion131: A Phase III, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti-Pd-L1 Antibody) in Combination With Paclitaxel Compared With Placebo With Paclitaxel for Patients With Previously Untreated Inoperable Locally Advanced or Metastatic Triple Negative Breast Cancer
Essai Clinique (Roche)   09 janvier 2024
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.
Bulletin du cancer   16 décembre 2023
Novel Treatment Approaches Under Investigation for HER2+ mBC
OncLive   23 novembre 2023
ICRG0101: Multicenter Large-scale Validation Study of the Interest of Broadband Spectroscopy Analysis (Femto/Attosecond by Infrared Laser) on Liquid Biopsies in Breast Cancer Screening
Essai Clinique (Centre Jean-Perrin)   21 novembre 2023
Treatment Approaches for Patients With HER2+ mBC and Brain Metastases
OncLive   16 novembre 2023
Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context.
Heliyon   10 novembre 2023